Skip to Main Content

Paper Details

Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment<sup/>.
Semin Ophthalmol
5
2017
Author NameAffiliation
Andre J Witkina Tufts Medical Center
Sunir J GargThe Retina Service of Wills Eye Hospital
Allen C HoThe Retina Service of Wills Eye Hospital
  • 1 - 3

Datasets